✦ LIBER ✦

9405 Spectrum of KIT and PDGFRA mutations in primary gastrointestinal stromal tumours: Polish clinical GIST registry experience

✍ Scribed by Wozniak, A.; Rutkowski, P.; Debiec-Rychter, M.; Siedlecki, J.; Michej, W.; Osuch, C.; Matlok, M.; Ruka, W.; Limon, J.

Book ID: 123399405
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 67 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71993-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Spectrum of KIT and PDGFRA mutations in

Spectrum of KIT and PDGFRA mutations in gastrointestinal stromal tumors: Polish GIST Registry experience

✍ Janusz Limon; Agnieszka Woniak; Czesaw Osuch; Marek Matlok; Maria Debiec-Rychter 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Clinical significance of oncogenic KIT a

Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours

✍ J Lasota; M Miettinen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 828 KB

The analysis of status and clinical impl

The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST)

✍ Chun-Yan Du; Ying-Qiang Shi; Ye Zhou; Hong Fu; Guangfa Zhao 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

## Abstract ## Background and objective to analyze the frequency and spectrum of KIT and platelet‐derived growth factor receptor‐alpha (PDGFRA) gene in a large series of study and to explore the clinical implication of mutations in the gastrointestinal stromal tumors (GISTs) in China. ## Method

Use of c-KIT/PDGFRA mutational analysis

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group

✍ M. Debiec-Rychter; H. Dumez; I. Judson; B. Wasag; J. Verweij; M. Brown; S. Dimit 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 309 KB